After closing at Rs 143.79 apiece on Thursday, the stock opened nearly 89% lower at Rs 16 apiece on NSE on Friday, after it turned ex-record date for the bonus issue and stock split.
As part of the stock split, every share with a face value of Rs 10 each was split into five equity shares with a face value of Rs 5 each. As part of the bonus issue, eligible shareholders will receive one bonus share for every share they own on the record date.
While a bonus issue and stock split increase the total number of outstanding shares, they do not change the company’s market capitalisation. However, they can improve liquidity and affordability, allowing more investors to add shares of the company to their portfolios.
Anlon Healthcare set April 24 (Friday) as the record date for the bonus issue and stock split. This means that only those shareholders who own the shares of the company in their demat accounts on that date will be eligible for the two corporate actions. Given the T+1 settlement norm, Thursday marked the last day investors could buy the shares of the company so that the shares are credited to their accounts by Friday and they become eligible for the bonus issue and stock split.
Anlon Healthcare share price
Anlon Healthcare shares made a muted market debut in September last year, listing at Rs 92 apiece on NSE. This marked a 1% premium over the IPO price of Rs 91 per share. This came even as the Rs 121-crore IPO of the pharmaceutical intermediates and active pharmaceutical ingredients (APIs) maker saw strong investor interest during its three days of public bidding, being subscribed over seven times its offer size.
Anlon Healthcare shares surged after the debut, rallying nearly 88% in a little over two months to hit an all-time high of Rs 172.75 apiece in November 2025. The stock, however, has declined from those levels.
(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of The Economic Times.)
